WCN26-4504 Era-Based Comparison of Outcomes in Kidney Transplantation for Diabetic Nephropathy

Read full text Summarise with VIRAT
Authors: Yoichi Kakuta, Soichi Matsumura, Shota Fukae, Masataka Kawamura, Shigeaki Nakazawa, Maho Tokuchi, Hiroaki Yonishi, Tomoko Namba‐Hamano, Atsushi Takahashi, Yoshitaka Isaka, Norio Nonomura
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Recent advances in diabetes therapy, including the development of sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists, have been shown to slow the progression of renal function decline. In kidney transplant recipients, these agents have also been increasingly prescribed, and short-term renoprotective effects have been reported. However, data regarding their long-term impact on graft survival and patient survival remain limited. In this study, we compared outcomes of kidney transplant recipients with diabetic nephropathy (DMN) as the primary disease before and after the introduction of these novel antidiabetic agents.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Chronic Kidney Disease and Diabetes Diabetes Treatment and Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105479–105479
Publication date
25 March 2026
Language
EN